在全球制药、生物科技产业的非上市股票交易及创业基金投资

本报告提供全球医药品、生物科技产业的非上市股票交易(私人股权)及创业基金(VC)交易的趋势相关分析、整体交易数量、交易额、各地区及收购方面企业的各种类的详细趋势、跨国交易概况、每主要的疾病、治疗领域的资本交易动向、主要企业之外地区的交易特性与趋势等调查，并将结果概述为以下内容。

分析中主要的用语

简介

制药、生物科技产业的主要趋势

主要的非上市股票(PE)、创业基金(VC)交易的统计资料

创业基金交易的主要指标

交易额的规模相关分析

各地区趋势分析

出口市场分析

每主要的治疗领域的资本交易分析

结论

关于Frost＆Sullivan

Vigilance and Equanimity are the Needs of the Hour

This study for the private equity and venture capital trends in the global pharmaceutical and biotechnology industry analyzes the various deals in the industry. The deals are analyzed based on number and average value. The trends are also observed based on the geographic region and buyer types. The study delves into the nature of cross border deals and also keeps into account various deal multiples such as deal value and investment rounds. The distribution of deals across key therapeutic areas has been dealt to understand the focus of investors and to highlight the key therapeutic areas in the near future. The analysis also includes geography-wise interest of buyers in regions across other geographies in terms both deal value and volume.

Table of Contents

• 1. Key Terms Used in the Study
• 2. Introduction
• 3. Key Trends in the Pharma and Biotech Industry
• 4. Key PEVC Statistics
• 5. VC Deals-Key Metrics
• 6. Deal Value Range Analysis
• 7. Geographic Analysis
• 8. Analysis of the Exit Market
• 9. Analysis of Deals Based on Key Therapeutic Areas
• 10. Conclusion
• 11. The Frost & Sullivan Story